Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial.
about
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesMarkers of exacerbation severity in chronic obstructive pulmonary diseaseModelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future.Pharmacoeconomics in COPD: lessons for the futureAssessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review.Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies.Costs of Treatment of Chronic Obstructive Pulmonary Disease.
P2860
Q30419928-CCD97916-D397-411B-950E-C563B503D9D8Q34691221-6F73C6DB-D8DF-470C-AFB1-BA0D45C25FF4Q35878722-3D850FB3-17BA-4E7F-BB23-F13CB85B9B0EQ36293842-171AB75E-4658-4D02-A2CB-A6C9AE93E1E7Q36859464-72E1B6DD-2E9F-408E-BBDB-4A3A3F45CB44Q37037387-4B5AFEF6-CBB5-4885-8370-CEC65DB3356AQ37992679-DEBBCEB4-C575-47E1-842D-5C8214E62C3EQ38099359-9A3B2664-2D78-4725-8659-12CC43FC33C8Q38348464-7165AF5A-7CD5-4EA4-BE0B-B004B7B46682Q38721028-90288F05-9D74-407A-8A2B-B2780FEC3484Q40072084-212C63FB-53E2-467A-B76E-E38B345194CF
P2860
Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@en
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@nl
type
label
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@en
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@nl
prefLabel
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@en
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@nl
P2093
P356
P1433
P1476
Cost-effectiveness of fluticas ...... zed, placebo-controlled trial.
@en
P2093
P304
P356
10.1053/RMED.2003.1441
P577
2003-03-01T00:00:00Z